Company has been in the pits for quite some time, trading at cash levels .. market is saying the IP is worthless despite having multiple clinical trials in progress and previous offers of $200M .
Sucks for exisiting long term holders but prime opportunity for new investors to get in at very attractive risk reward ratio.
Ann: Initial Results in First 16 DFU Patients Expected in Q1 2024, page-2
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.030(12.5%) |
Mkt cap ! $48.50M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 29.5¢ | 26.0¢ | $113.1K | 420.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4999 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 3935 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |